What is Lucid Diagnostics's stock issuance proceeds?

Lucid Diagnostics (LUCD) reported stock issuance proceeds of $20K in Q1 2026.

How has Lucid Diagnostics's stock issuance proceeds changed year-over-year?

Lucid Diagnostics's stock issuance proceeds increased by 566.7% year-over-year, from $3K to $20K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Lucid Diagnostics LUCD Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Castle BiosciencesCSTL

$322K+1,689%

Guardant HealthGH

$3.65M+375%

Biodesix, Inc.BDSX

$17.21M—

Insight Molecular Diagnostics Inc. Common StockIMDX

$26.02M-10.7%

Fulgent Genetics, Inc.FLGT

$9K—

Personalis, Inc.PSNL

$20.95M+17.8%

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Return on equity-710.6%—

Debt / equity0.4×—

Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's stock issuance proceeds?: Lucid Diagnostics (LUCD) reported stock issuance proceeds of $20K in Q1 2026.
How has Lucid Diagnostics's stock issuance proceeds changed year-over-year?: Lucid Diagnostics's stock issuance proceeds increased by 566.7% year-over-year, from $3K to $20K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.